retatrutide phase 2 nejm 2023 obesity trial jastreboff Trial: 48-Week Weight Loss Results Explained – Bolt Pharmacy Retatrutide: Phase 3 Results (Up

PMID: 3 LiJXCumminsCL

About 51% of Americans who want to lose weight expect that doing so will lead to improved confidence at work, and 48% expect to be able to present a more professional appearance

Positioning of GLP-1 RAs as Add-On Therapy to SGLT2is Data providing direct comparisons between SGLT2is and GLP-1 RAs to allow assessment of optimal positioning and sequencing of these agents are very limited

iFIT assumes no responsibility for any personal injury or damage sustained by any recommendations, opinions, or advice given in this article

However, weight loss through dietary control and regular exercise is considered a fundamental and critical treatment measure, especially in obese or overweight individuals with PCOS